Dr. Agarwal'S Eye Hospital Limited

As of March 31, 2026, Dr. Agarwal'S Eye Hospital Limited carries a market capitalization of 22.71B, placing it among publicly traded companies globally. Its enterprise value stands at 25.02B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of March 31, 2026, Dr. Agarwal'S Eye Hospital Limited has 4.83M shares outstanding.

These figures are as of March 31, 2026.

As of March 31, 2026, Dr. Agarwal'S Eye Hospital Limited maintains a current ratio of 1.23, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended March 31, 2026.

Over the twelve months ended March 31, 2026, Dr. Agarwal'S Eye Hospital Limited recorded 171.10M in income tax expense.

As of the close on October 22, 2026, Dr. Agarwal'S Eye Hospital Limited's stock has declined approximately 5.66% over the past 52 weeks. The 50-day moving average sits at 5,245.53, while the 200-day moving average is 5,008.82.

As of March 31, 2026, Dr. Agarwal'S Eye Hospital Limited holds 956.90M in cash and equivalents against 3.26B in total debt, resulting in a net debt position of 751.80M. Total book value stands at 3.46B, with working capital of 251.60M providing operational flexibility.